X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Pharma with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs TTK HEALTHCARE - Comparison Results

GSK PHARMA    Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA TTK HEALTHCARE GSK PHARMA/
TTK HEALTHCARE
 
P/E (TTM) x 66.9 27.1 247.2% View Chart
P/BV x 11.7 6.0 196.3% View Chart
Dividend Yield % 1.1 0.5 221.9%  

Financials

 GSK PHARMA   TTK HEALTHCARE
EQUITY SHARE DATA
    GSK PHARMA
Mar-17
TTK HEALTHCARE
Mar-14
GSK PHARMA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3,838663 578.5%   
Low Rs2,637399 660.9%   
Sales per share (Unadj.) Rs354.2535.6 66.1%  
Earnings per share (Unadj.) Rs39.815.9 249.4%  
Cash flow per share (Unadj.) Rs42.920.0 214.1%  
Dividends per share (Unadj.) Rs30.004.00 750.0%  
Dividend yield (eoy) %0.90.8 123.1%  
Book value per share (Unadj.) Rs236.9137.6 172.2%  
Shares outstanding (eoy) m84.707.77 1,090.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x9.11.0 921.7%   
Avg P/E ratio x81.433.3 244.4%  
P/CF ratio (eoy) x75.526.5 284.7%  
Price / Book Value ratio x13.73.9 354.0%  
Dividend payout %75.425.1 300.8%   
Avg Mkt Cap Rs m274,2164,127 6,643.8%   
No. of employees `0004.71.7 275.0%   
Total wages/salary Rs m4,830607 796.2%   
Avg. sales/employee Rs Th6,387.02,436.7 262.1%   
Avg. wages/employee Rs Th1,028.3355.2 289.5%   
Avg. net profit/employee Rs Th717.172.5 988.5%   
INCOME DATA
Net Sales Rs m30,0004,162 720.8%  
Other income Rs m72861 1,189.9%   
Total revenues Rs m30,7284,223 727.6%   
Gross profit Rs m4,190197 2,125.7%  
Depreciation Rs m26332 829.7%   
Interest Rs m030 0.0%   
Profit before tax Rs m4,655197 2,366.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m4570-   
Tax Rs m1,74473 2,395.6%   
Profit after tax Rs m3,368124 2,718.3%  
Gross profit margin %14.04.7 294.9%  
Effective tax rate %37.537.0 101.2%   
Net profit margin %11.23.0 377.1%  
BALANCE SHEET DATA
Current assets Rs m16,7421,629 1,028.0%   
Current liabilities Rs m7,2021,058 680.9%   
Net working cap to sales %31.813.7 231.8%  
Current ratio x2.31.5 151.0%  
Inventory Days Days5230 174.0%  
Debtors Days Days2134 61.9%  
Net fixed assets Rs m8,635556 1,552.3%   
Share capital Rs m84778 1,090.1%   
"Free" reserves Rs m19,222878 2,188.5%   
Net worth Rs m20,0691,069 1,876.8%   
Long term debt Rs m10159 6.3%   
Total assets Rs m30,0382,399 1,251.9%  
Interest coverage xNM7.6-  
Debt to equity ratio x00.1 0.3%  
Sales to assets ratio x1.01.7 57.6%   
Return on assets %11.26.4 174.9%  
Return on equity %16.811.6 144.8%  
Return on capital %25.518.5 138.0%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m52833 1,604.9%   
Fx outflow Rs m7,19363 11,383.1%   
Net fx Rs m-6,665-30 22,004.0%   
CASH FLOW
From Operations Rs m2,360127 1,864.1%  
From Investments Rs m3,008-146 -2,060.3%  
From Financial Activity Rs m-5,10822 -23,322.4%  
Net Cashflow Rs m2603 10,412.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 50.7 0.0 -  
Indian inst/Mut Fund % 10.2 3.7 275.7%  
FIIs % 23.8 5.2 457.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 15.4 25.8 59.7%  
Shareholders   102,036 12,723 802.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   DR. DATSONS LABS  STRIDES SHASUN LTD  FDC LTD.  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare GSK PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

GSK PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 6.4%

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 6.4% YoY). Sales on the other hand came in at Rs 7 bn (down 4.5% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Jun 21, 2018 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - DISHMAN PHARMA COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS